AstraZeneca, Merck ovarian cancer treatment improves progression-free survival

AstraZeneca Plc and Merck & Co Inc said on Monday their treatment for newly diagnosed advanced ovarian

 
– Reuters: Money News

• Share on Facebook
• Tweet it
• Pin it
• Share it
• Email